Delivery Order SPE2DB20D3101-SPE2DB24FQYL0
Award Date
1/4/24
Potential Completion Date
1/5/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a potential value of $2,194.16 and a completion date of January 26, 2024. This award does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the...
This federal contract award is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $4,406.90. The contract has a completion date of February 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA). The $7,035.03 firm fixed price contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 5, 2024 with a completion date of September 6, 2024. The contract is a delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp is registered in the System for Award...
This federal contract award is for the delivery of the pharmaceutical product "WEGOVY 1 MG/0.5 ML PEN 0.5ML" to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is a Delivery Order with a Firm Fixed Price of $1,214.15 and has an ultimate completion date of February 21, 2024. Amerisourcebergen...
This federal contract award is for the delivery of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA). The contract, valued at $3,291.24, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract is a delivery order and is priced on a firm fixed-price basis. The contract has an ultimate completion date of December 12, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,046.77 firm fixed-price delivery order is for the drug product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has an ultimate completion date of March 19, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $3,645.51 and a period of performance through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to...
This federal contract award is for the delivery of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, the Corporate Office division of the larger Amerisourcebergen Corporation, which is a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $3,190.48 and has an ultimate...
This federal contract award is for the delivery of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA). The contract, valued at $1,473.82, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a delivery date of June 12, 2023 and is a firm-fixed-price delivery order. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award is for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The $7,425.59 fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...